Psagot Value Holdings’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-220
Closed -$22K 469
2019
Q3
$22K Hold
220
﹤0.01% 356
2019
Q2
$20K Sell
220
-12,800
-98% -$1.22M ﹤0.01% 365
2019
Q1
$1.23M Sell
13,020
-142,420
-92% -$12.5M 0.05% 161
2018
Q4
$9.96M Sell
155,440
-5,545
-3% -$409K 0.46% 57
2018
Q3
$14.4M Sell
160,985
-123,925
-43% -$11M 0.64% 42
2018
Q2
$22.6M Buy
284,910
+201,502
+242% +$16.7M 1.05% 28
2018
Q1
$7.44M Sell
83,408
-16,700
-17% -$1.6M 0.32% 59
2017
Q4
$10.4M Buy
100,108
+25,106
+33% +$2.83M 0.45% 48
2017
Q3
$10.9M Buy
75,002
+1,899
+3% +$259K 0.46% 45
2017
Q2
$9.49M Hold
73,103
0.41% 47
2017
Q1
$9.1M Buy
73,103
+24,155
+49% +$2.89M 0.38% 48
2016
Q4
$5.67M Buy
48,948
+24,662
+102% +$2.75M 0.24% 61
2016
Q3
$2.54M Sell
24,286
-4,049
-14% -$438K 0.11% 98
2016
Q2
$2.79M Sell
28,335
-56,968
-67% -$5.89M 0.12% 95
2016
Q1
$8.54M Buy
85,303
+9,821
+13% +$1.01M 0.35% 62
2015
Q4
$9.04M Buy
75,482
+761
+1% +$88K 0.32% 63
2015
Q3
$8.08M Buy
74,721
+72,064
+2,712% +$8.94M 0.29% 66
2015
Q2
$308K Buy
2,657
+2,465
+1,284% +$282K 0.01% 227
2015
Q1
$22K Sell
192
-2,538
-93% -$303K ﹤0.01% 321
2014
Q4
$305K Sell
2,730
-6,530
-71% -$689K 0.01% 204
2014
Q3
$878K Buy
9,260
+4,630
+100% +$418K 0.03% 155
2014
Q2
$398K Sell
4,630
-4,630
-50% -$352K 0.01% 184
2014
Q1
$646K Hold
9,260
0.02% 176
2013
Q4
$782K Sell
9,260
-21,200
-70% -$1.68M 0.03% 167
2013
Q3
$2.35M Buy
30,460
+10
+0% +$701 0.09% 103
2013
Q2
$1.78M Buy
+30,450
New +$1.83M 0.08% 106

Other funds holding CELG

Psagot Value Holdings's CELG Position: Q4 2019 in Review

Psagot Value Holdings sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 220 shares — an estimated $22K sold.

Psagot Value Holdings first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $22.6M in Q2 2018. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Psagot Value Holdings reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Psagot Value Holdings sold 220 Celgene Corp shares in Q4 2019, an estimated $22K.
  • Psagot Value Holdings first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
  • Psagot Value Holdings's Celgene Corp position peaked at $22.6M in Q2 2018.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Psagot Value Holdings's 13F filing for Q4 2019, filed 18 Feb 2020.